Actelion Pays $65M To Settle Tracleer Antitrust Class Suit
By Bryan Koenig · March 6, 2026, 7:29 PM EST
Actelion Pharmaceuticals Ltd. agreed to pay $65 million to resolve antitrust claims from a certified class accusing it of illegally denying generics companies the samples they need to produce generic versions...
To view the full article, register now.